Biogen Idec to Present at the UBS Global Life Sciences Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ/BIIB) announced today that its presentation at the UBS Global Life Sciences Conference will be webcast live via the internet, on Tuesday, September 22nd at 9:00 a.m. ET. To access the live webcast, please visit Biogen Idec’s homepage, www.biogenidec.com. An archived version of the webcast will be available for 14 days following the presentation.
About Biogen Idec
Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.
Contact:
Biogen Idec
Karen Jewell, 617-679-2757
Investor Relations
